Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV

Comparison of the APRI and FIB-4 index

Tony Trang, John R. Petersen, Ned Snyder

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Introduction: The APRI and FIB-4 index are markers that have been proposed for the evaluation of hepatic fibrosis in patients co-infected with HIV and HCV. Methods: We retrospectively compared these 2 indices in 81 co-infected patients staged by liver biopsy. Results: The FIB-4 index was superior to the APRI for the differentiation of mild from significant fibrosis in both predictive values and area under the receiver operator curve (AUROC). The tests were comparable for the differentiation of mild/moderate from advanced fibrosis. Conclusion: These tests could be used to evaluate co-infected patients for treatment, and exclude those that do not need periodic screening for hepatocellular carcinoma.

Original languageEnglish (US)
Pages (from-to)51-54
Number of pages4
JournalClinica Chimica Acta
Volume397
Issue number1-2
DOIs
StatePublished - Nov 2008

Fingerprint

Biopsy
Liver
Screening
Fibrosis
HIV
Hepatocellular Carcinoma
Therapeutics

Keywords

  • Alanine aminotransferase
  • Aspartate aminotransferase
  • Fibrosis
  • Hepatitis C
  • Human immunodeficiency virus (HIV)
  • Platelets

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV : Comparison of the APRI and FIB-4 index. / Trang, Tony; Petersen, John R.; Snyder, Ned.

In: Clinica Chimica Acta, Vol. 397, No. 1-2, 11.2008, p. 51-54.

Research output: Contribution to journalArticle

@article{6d97060bc8ae4b7e86952e026d485d90,
title = "Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: Comparison of the APRI and FIB-4 index",
abstract = "Introduction: The APRI and FIB-4 index are markers that have been proposed for the evaluation of hepatic fibrosis in patients co-infected with HIV and HCV. Methods: We retrospectively compared these 2 indices in 81 co-infected patients staged by liver biopsy. Results: The FIB-4 index was superior to the APRI for the differentiation of mild from significant fibrosis in both predictive values and area under the receiver operator curve (AUROC). The tests were comparable for the differentiation of mild/moderate from advanced fibrosis. Conclusion: These tests could be used to evaluate co-infected patients for treatment, and exclude those that do not need periodic screening for hepatocellular carcinoma.",
keywords = "Alanine aminotransferase, Aspartate aminotransferase, Fibrosis, Hepatitis C, Human immunodeficiency virus (HIV), Platelets",
author = "Tony Trang and Petersen, {John R.} and Ned Snyder",
year = "2008",
month = "11",
doi = "10.1016/j.cca.2008.07.009",
language = "English (US)",
volume = "397",
pages = "51--54",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV

T2 - Comparison of the APRI and FIB-4 index

AU - Trang, Tony

AU - Petersen, John R.

AU - Snyder, Ned

PY - 2008/11

Y1 - 2008/11

N2 - Introduction: The APRI and FIB-4 index are markers that have been proposed for the evaluation of hepatic fibrosis in patients co-infected with HIV and HCV. Methods: We retrospectively compared these 2 indices in 81 co-infected patients staged by liver biopsy. Results: The FIB-4 index was superior to the APRI for the differentiation of mild from significant fibrosis in both predictive values and area under the receiver operator curve (AUROC). The tests were comparable for the differentiation of mild/moderate from advanced fibrosis. Conclusion: These tests could be used to evaluate co-infected patients for treatment, and exclude those that do not need periodic screening for hepatocellular carcinoma.

AB - Introduction: The APRI and FIB-4 index are markers that have been proposed for the evaluation of hepatic fibrosis in patients co-infected with HIV and HCV. Methods: We retrospectively compared these 2 indices in 81 co-infected patients staged by liver biopsy. Results: The FIB-4 index was superior to the APRI for the differentiation of mild from significant fibrosis in both predictive values and area under the receiver operator curve (AUROC). The tests were comparable for the differentiation of mild/moderate from advanced fibrosis. Conclusion: These tests could be used to evaluate co-infected patients for treatment, and exclude those that do not need periodic screening for hepatocellular carcinoma.

KW - Alanine aminotransferase

KW - Aspartate aminotransferase

KW - Fibrosis

KW - Hepatitis C

KW - Human immunodeficiency virus (HIV)

KW - Platelets

UR - http://www.scopus.com/inward/record.url?scp=51249119841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51249119841&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2008.07.009

DO - 10.1016/j.cca.2008.07.009

M3 - Article

VL - 397

SP - 51

EP - 54

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -